Sildenafil citrate

Trade Name: 
Revatio IV
Manufacturer/Distributor: 
Pfizer
1-800-387-4974
Classification: 
cGMP-Specific Phosphodiesterase Type 5 Inhibitor
ATC Class: 
G04BE03
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2010/01/14
Date Marketed in Canada (yyyy/mm/dd): 
2010/08/31
Presentation: 
Injection: 0.8 mg/mL, 12.5 ml vial. DIN: 02351611
Comments: 
New strength. For the treatment of pulmonary arterial hypertension.